Work

Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure

Year: 2023

Type: article

Source: Journal of Cardiac Failure

DOI: 10.1016/j.cardfail.2023.05.018

Authors: VEENA S. RAO, JUAN B. IVEY-MIRANDA, ZACHARY L. COX, JULIETA MORENO-VILLAGOMEZ, JEFFREY M. TESTANI

Institutions: Yale University, Mexican Social Security Institute, Lipscomb University, Vanderbilt University Medical Center

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Sanofi, National Institutes of Health, Relypsa, National Heart, Lung, and Blood Institute

Awards: Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure, G1728086108, Cardio-renal phenotype and prognosis in chronic heart failure, Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure, G3298752730, Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosis, Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study

OpenAlex ID: W4379927822

FWCI: 1.669

Cites: 34

Cited by: 9

Related to: 10